Sonoma Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/05/2024
Sonoma Pharmaceuticals Stock Forecast and Price Target
Sonoma Pharmaceuticals's stock is projected to advance by 2066.67% from the previous closing price if it reaches the average target of $3.25 by the year's end, as reputable analysts recently projected. This potential upside is calculated on a high-end estimate of $3.25 and a low-end estimate of $3.25. If you're thinking of investing in SNOA stock, it might be good to look at its rivals too.
2066.67% Upside
Sonoma Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last zero years, Sonoma Pharmaceuticals's Price has grown, increasing from $0.00 to $0.00 – a growth of 100.00%. The next year looks promising for Sonoma Pharmaceuticals, with analysts predicting Fair Value of $0.17 – an increase of 100.00%. Over the next six years, experts anticipate that Sonoma Pharmaceuticals's Fair Value will grow at a rate of 100.00%.
.jpg)
Sonoma Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last zero years, Sonoma Pharmaceuticals's EPS has grown, increasing from $0.00 to $0.00 – a growth of 100.00%. The next year looks promising for Sonoma Pharmaceuticals, with analysts predicting EPS of $-0.45 – an increase of 100.00%. Over the next six years, experts anticipate that Sonoma Pharmaceuticals's EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)